William Blair Investment Management, LLC Catalent, Inc. Transaction History

William Blair Investment Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$47.06 - $56.64 $96.1 Million - $116 Million	-2,042,550 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$47.45 - $58.05 $14.9 Million - $18.2 Million	-313,040 Reduced 13.29%	2,042,550 $97.3 Million
Q2 2019 Aug 09, 2019	SELL	$39.26 - $54.21 $68 Million - $93.9 Million	-1,731,332 Reduced 42.36%	2,355,590 $128 Million
Q1 2019 May 10, 2019	SELL	$29.84 - $43.92 $132,340 - $194,785	-4,435 Reduced 0.11%	4,086,922 $166 Million
Q4 2018 Feb 13, 2019	SELL	$29.95 - $46.34 $8.17 Million - $12.6 Million	-272,820 Reduced 6.25%	4,091,357 $128 Million
Q3 2018 Nov 13, 2018	BUY	$40.12 - $45.55 $36.9 Million - $41.9 Million	920,869 Added 26.74%	4,364,177 $199 Million
Q2 2018 Aug 14, 2018	BUY	$38.72 - $42.52 $551,914 - $606,080	14,254 Added 0.42%	3,443,308 $144 Million
Q1 2018 May 14, 2018	BUY	$39.4 - $47.39 $135 Million - $163 Million	3,429,054 New	3,429,054 $141 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of William Blair Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on William Blair Investment Management, LLC with notifications on news.